A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00346645
Recruitment Status : Terminated (stopped after planned interim analysis for lack of efficacy)
First Posted : June 30, 2006
Last Update Posted : February 6, 2013
Information provided by:
Gustave Roussy, Cancer Campus, Grand Paris

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : May 2007
  Study Completion Date : December 2007